Dag Hofso
Overview
Explore the profile of Dag Hofso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
847
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hauge J, Waerp C, Hofso D, Abedini S
Tidsskr Nor Laegeforen
. 2024 Dec;
144(15).
PMID: 39692666
Background: Isolated central hypothyroidism, although rare, has been documented in case reports in patients with chronic kidney disease (CKD) treated with roxadustat, a novel agent in the treatment of renal...
2.
Wahlstrom A, Aydin O, Olsson L, Sjoland W, Henricsson M, Lundqvist A, et al.
EBioMedicine
. 2024 Aug;
106:105265.
PMID: 39096744
Background: Bariatric surgery is an effective treatment option for obesity and provides long-term weight loss and positive effects on metabolism, but the underlying mechanisms are poorly understood. Alterations in bile...
3.
Svanevik M, Lorentzen J, Borgeraas H, Sandbu R, Seip B, Medhus A, et al.
Lancet Diabetes Endocrinol
. 2023 Jul;
11(8):555-566.
PMID: 37414071
Background: Little is known about the comparative effects of various bariatric procedures on patient-reported outcomes. We aimed to compare 3-year effects of gastric bypass and sleeve gastrectomy on patient-reported outcome...
4.
Barstad L, Johnson L, Borgeraas H, Hofso D, Svanevik M, Smastuen M, et al.
Am J Clin Nutr
. 2023 Feb;
117(3):586-598.
PMID: 36811476
Background: The randomized Oseberg study compared the effects of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), on the 1-y remission of type 2 diabetes and β-cell function (primary outcomes)....
5.
Seeberg K, Hofso D, Borgeraas H, Grimnes J, Fatima F, Thomas Seeberg L, et al.
BMC Gastroenterol
. 2022 Nov;
22(1):448.
PMID: 36336684
Background: Obesity, non-alcoholic fatty liver disease (NAFLD) and insulin resistance are three pathological conditions highly correlated, but this relationship is not fully elucidated. Hence, we aimed to assess the association...
6.
Lorentzen J, Medhus A, Hofso D, Svanevik M, Seip B, Hjelmesaeth J
Int J Obes (Lond)
. 2022 Aug;
46(10):1936-1937.
PMID: 35933446
No abstract available.
7.
Borgeraas H, Hofso D, Svanevik M, Hjelmesaeth J
J Gastrointest Surg
. 2022 Aug;
26(9):2031-2032.
PMID: 35920967
No abstract available.
8.
Borgeraas H, Hofso D, Hertel J, Hjelmesaeth J
Obes Rev
. 2022 Feb;
23(4):e13432.
PMID: 35112787
No abstract available.
9.
Fatima F, Hjelmesaeth J, Hertel J, Svanevik M, Sandbu R, Smastuen M, et al.
Obes Surg
. 2022 Jan;
32(3):801-809.
PMID: 34982397
Background: Prediction of type 2 diabetes (T2DM) remission is an important part of risk-benefit assessment before bariatric surgery. Study Design: Advanced-DiaRem (Ad-DiaRem) and ABCD diabetes remission scores for sleeve gastrectomy...
10.
Seeberg K, Borgeraas H, Hofso D, Smastuen M, Kvan N, Grimnes J, et al.
Ann Intern Med
. 2021 Nov;
175(1):74-83.
PMID: 34843380
Background: Weight loss improves fatty liver disease. No randomized trial has compared the effects of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) on liver fat content and fibrosis. Objective:...